International Lyme Disease Studies Highlight Delayed Diagnosis and Neurologic Symptoms

Studies from multiple countries report delayed diagnosis.
Neurologic and psychiatric symptoms were commonly described.
Recognition gaps remain an ongoing concern.

International Lyme disease studies have identified recurring themes involving delayed diagnosis, neurologic symptoms, psychiatric complications, persistent symptoms, and public health recognition gaps.

Although surveillance systems and diagnostic approaches vary between countries, several reports from Canada, Germany, and Mexico describe similar clinical challenges involving recognition of Lyme disease and its complications.

These studies do not necessarily prove that Lyme disease presents differently around the world. However, they highlight recurring concerns involving diagnosis patterns, neurologic manifestations, carditis recognition, and persistent symptoms following treatment.

Recognition challenges in Lyme disease are not new. Early observations by Polly Murray and clinicians in Lyme, Connecticut helped identify children initially believed to have juvenile rheumatoid arthritis who were later recognized as having Lyme disease.

Although two-tier antibody testing later became a standard diagnostic approach, clinicians and researchers have continued to discuss limitations involving early disease detection, neurologic presentations, and patients with persistent or fluctuating symptoms.

---

Delayed Diagnosis Remains a Recurring Theme

Despite differences in healthcare systems and surveillance methods, several recurring themes appeared across international reports.

Several studies describe substantial delays before patients receive a Lyme disease diagnosis.

In a German study of 252 patients, investigators reported that:

• Patients visited nearly 8 physicians on average before diagnosis
• Diagnosis occurred approximately 8 years after the recalled tick bite
• Less than half were diagnosed within the first 5 years of symptoms

The authors also described cognitive, psychiatric, and neurologic symptoms alongside reduced quality of life.

Related: Lyme Disease in Germany: Delayed Diagnosis and Neuropsychiatric Symptoms

---

Neurologic Lyme Disease Across Multiple Countries

Different countries have reported varying challenges involving Lyme disease recognition, neurologic complications, and long-term outcomes.

Canadian surveillance data identified:

• Bell’s palsy in both children and adults
• Increasing reports of neurologic manifestations over time
• Neurologic symptoms across multiple age groups

Investigators reported that neurologic manifestations increased from 15% (2009–2015) to 20% (2016–2019).

The increase in neurologic cases highlights the importance of recognizing Lyme disease presentations beyond erythema migrans rash alone.

Related: Lyme Disease in Canada: Symptoms, Neurologic Cases, and Regional Trends

---

Psychiatric and Cognitive Symptoms

International studies have also reported psychiatric and cognitive symptoms associated with Lyme disease.

The German cohort described:

• Depressive symptoms
• Attention and memory impairment
• Sleep disruption
• Reduced quality of life
• Neuropsychiatric symptoms

These findings align with broader concerns regarding neuropsychiatric Lyme disease, brain fog, and persistent cognitive dysfunction reported in other studies.

Related: Neuropsychiatric Lyme Disease

---

Recognition of Lyme Carditis

Recognition gaps involving Lyme carditis have also been described internationally.

A case report from Mexico described a young woman who developed advanced atrioventricular block associated with Lyme carditis.

The authors argued that Lyme disease was under-recognized despite evidence of tick exposure and positive testing.

The patient ultimately required permanent pacemaker placement after delayed recognition of Lyme carditis.

Related: Lyme Carditis Symptoms May Go Undiagnosed in Mexico

---

Persistent Symptoms After Treatment

Several studies also described persistent or relapsing symptoms following treatment.

In the German study:

• Nearly 73% reported improvement after antibiotic treatment
• 93% reported relapse of symptoms after treatment completion

Persistent symptoms following treatment remain an area of ongoing clinical research and discussion.

Related: Post-Treatment Lyme Disease Syndrome

---

Public Health Awareness and Surveillance Differences

International studies also reveal differences in surveillance systems, diagnostic practices, and public health recognition.

Differences in surveillance systems, testing practices, and reporting methods may influence how Lyme disease cases are categorized across countries.

Canadian surveillance data identified changing patterns over time, including decreases in late disseminated disease after 2016 and increased reporting of neurologic manifestations.

Meanwhile, investigators from Mexico described ongoing skepticism regarding Lyme disease recognition despite published evidence of Lyme carditis and serologic positivity.

These findings suggest that regional awareness, surveillance systems, and diagnostic approaches may influence how Lyme disease is identified and reported.

---

Clinical Perspective

International Lyme disease studies continue to highlight several recurring themes:

• Delayed diagnosis
• Neurologic manifestations
• Psychiatric and cognitive symptoms
• Recognition gaps involving Lyme carditis
• Persistent symptoms following treatment
• Differences in surveillance and public health awareness

Together, these international studies reinforce the importance of recognizing neurologic, psychiatric, cardiac, and persistent manifestations of Lyme disease while continuing to improve surveillance, diagnosis, and long-term patient care.

---

Frequently Asked Questions

Do Lyme disease symptoms vary between countries?
Different studies report varying symptom patterns and recognition trends, although differences in surveillance systems and diagnostic methods may also influence findings.

Can Lyme disease cause neurologic symptoms internationally?
Yes. Studies from multiple countries have reported Bell’s palsy, neuroborreliosis, cognitive symptoms, and other neurologic manifestations.

Why is Lyme disease diagnosis delayed in some patients?
Diagnosis may be delayed because symptoms can overlap with other conditions, fluctuate over time, or occur without a recalled tick bite or rash.

Do patients report persistent symptoms after treatment?
Some studies describe persistent or relapsing symptoms after treatment, although the mechanisms remain an area of ongoing investigation.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention